SCHEMBL20512274

SCHEMBL20512274

Cc1ccc(S(=O)(=O)NCCC#CC(O)c2cccc3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.43
▸ HKDC1 Q2TB90 1/20 0.43
▸ USP2 O75604 3/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ NPY5R Q15761 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HMOX1 P09601 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20512258 0.82 NPSR1 (0.51) CYP19A1USP2MEN1KMT2ACYP1A2
SCHEMBL13040850 0.76 CASR (0.40) CYP19A1HKDC1USP2MEN1KMT2A
SCHEMBL20512228 0.76 EGFR (0.45) CYP19A1MEN1KMT2AALDH1A1NPSR1
SCHEMBL20512261 0.75 CA12 (0.52) CYP19A1USP2MEN1KMT2ACYP1A2
SCHEMBL20512253 0.75 ALDH1A1 (0.51) MEN1KMT2AALDH1A1MAPTL3MBTL1
SCHEMBL20512265 0.74 ALDH1A1 (0.50) USP2MEN1KMT2AALDH1A1CA12
SCHEMBL20512229 0.73 ALDH1A1 (0.53) MEN1KMT2ACYP1A2CYP3A4ALDH1A1
SCHEMBL20512232 0.73 ALDH1A1 (0.48) USP2MEN1KMT2ACYP2C9ALDH1A1
SCHEMBL20512263 0.72 KMT2A (0.56) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL20512235 0.72 CA1 (0.46) CYP19A1MEN1KMT2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180354963-A1 NOVEL LACTONES PURDUE RESEARCH FOUNDATION (US) 2018-12-13 — — US disclosed
US-10138252-B1 Lactones PURDUE RESEARCH FOUNDATION (US) 2018-11-27 — — US disclosed
US-20180305371-A1 NOVEL LACTONES PURDUE RESEARCH FOUNDATION (US) 2018-10-25 — — US disclosed
US-10087190-B1 Lactones PURDUE RESEARCH FOUNDATION (US) 2018-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180354963-A1 NOVEL LACTONES DHPS, FDPS, LSS CYP19A1 1049/4885HKDC1 3198/4885USP2 3016/4885
US-20180305371-A1 NOVEL LACTONES DHPS, FDPS, LSS CYP19A1 1049/4885HKDC1 3198/4885USP2 3016/4885
US-10138252-B1 Lactones DHPS, FDPS, LSS CYP19A1 850/4885HKDC1 3232/4885USP2 2830/4885
US-10087190-B1 Lactones DHPS, FDPS, LSS CYP19A1 850/4885HKDC1 3232/4885USP2 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback